Joel Block to Adalimumab
This is a "connection" page, showing publications Joel Block has written about Adalimumab.
Connection Strength
0.070
-
Rare infection in patient with rheumatoid arthritis treated with adalimumab. BMJ Case Rep. 2019 Nov 21; 12(11).
Score: 0.038
-
Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis. Arthritis Rheumatol. 2017 04; 69(4):866-867.
Score: 0.032